Episode Details

Back to Episodes
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas

Episode 37: Differentiating Yourself in Crowded Therapeutic Areas

Published 6 years, 9 months ago
Description
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us